자동 세포 계수기 시장 보고서(2026년)
Automated Cell Counter Global Market Report 2026
상품코드 : 1921386
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,559,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,481,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,403,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

자동 세포 계수기 시장 규모는 최근 수년간 괄목할 만한 성장세를 보이고 있습니다. 2025년 57억 5,000만 달러에서 2026년 61억 2,000만 달러로 연평균 6.6% 성장할 것으로 예측됩니다. 지난 수년간의 성장은 수동 세포 계수의 한계에 대한 의존도 증가, 임상 진단 검사량 증가, 생명과학 연구 자금 증가, 의약품 품질관리 프로세스의 확대, 정확하고 재현 가능한 실험 결과에 대한 수요에 기인하는 것으로 보입니다.

자동 세포 계수기 시장 규모는 향후 수년간 견고한 성장이 예상됩니다. 2030년에는 76억 8,000만 달러에 달할 것으로 예상되며, CAGR은 5.8%를 보일 것으로 전망됩니다. 예측 기간 중의 성장 요인으로는 맞춤형 의료 연구의 발전, 임상 실험실의 자동화 확대, POC(Point of Care) 진단의 보급 확대, 세포 기반 분석 기술의 발전, 생명공학 연구시설의 확대 등을 들 수 있습니다. 예측 기간의 주요 동향으로는 임상 진단 분야의 자동 세포 계수기 도입 확대, 연구소의 고처리량 세포 분석 수요 증가, 광학식 자동 세포 계수 시스템에 대한 선호도 증가, 바이오의약품 연구개발 분야의 자동 세포 계수기 보급 확대, 일상적인 실험실 워크플로우에 자동 세포 계수 시스템 통합 증가 등을 들 수 있습니다. 세포 계수 시스템의 일상적인 실험실 워크플로우에 자동 세포 계수 시스템의 통합 증가 등을 들 수 있습니다.

맞춤형 의료의 보급 확대가 자동 세포 계수기 시장의 성장을 촉진할 것으로 예측됩니다. 맞춤의료란 환자의 유전적, 환경적, 생활습관적 요인을 고려하여 개개인의 특성에 맞는 치료법을 설계하는 것입니다. 유전자 연구와 기술의 발전으로 환자의 고유한 프로파일에 기반한 정밀치료가 가능해지면서 이러한 추세는 더욱 확대되고 있습니다. 자동 세포 계수기는 환자 고유의 세포 집단을 신속하고 정확하게 분석하여 개인별 세포 프로파일에 따른 맞춤형 치료를 지원함으로써 맞춤형 의료에 있으며, 매우 중요한 역할을 합니다. 예를 들어 맞춤형 의료연합(PMC)의 보고에 따르면 2024년 2월 FDA는 희귀질환 환자를 위한 16건의 새로운 개인맞춤형 치료제를 승인했습니다. 이는 2022년 6건 승인에 비해 크게 증가한 수치입니다. 맞춤형 의료의 도입 확대 추세는 자동 세포 계수기 시장의 성장을 촉진하는 주요 요인이 될 것입니다.

자동 세포 계수기 시장의 주요 기업은 AI 자동 세포배양 시스템 등 지능형 알고리즘과 머신러닝을 접목하여 생물학 연구 및 바이오 제조의 세포 증식 및 확장성 프로세스의 효율성과 자동화를 촉진하고 있습니다. AI 자동화 세포배양 시스템은 실험실 환경에서 인공지능을 활용하여 세포의 증식과 유지를 자율적으로 모니터링, 관리, 최적화합니다. 예를 들어 Molecular Devices LLC는 2023년 10월, 복잡한 세포배양 공정을 간소화하는 머신러닝 기반 소프트웨어를 갖춘 'CellXpress.ai' 자동화 세포배양 시스템을 발표했습니다. 이 시스템은 인큐베이터, 액체 핸들러, 이미저를 통합하여 수유 및 계대 스케줄의 자동화를 실현함으로써 연구자의 실험실 작업의 효율성과 제어력을 향상시킵니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계의 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSA
영문 목차

영문목차

An automated cell counter is a specialized instrument used in laboratory settings to rapidly and accurately count cells within a biological sample. These instruments employ advanced optical or electronic technologies to automate the cell counting process, eliminating the need for manual counting under a microscope.

The main types of products in an automated cell counter include consumable accessories and instruments. Consumables and accessories in automated cell counting comprise items such as reagents, calibration standards, and disposable slides or microplates, crucial for conducting cell counting procedures accurately and efficiently. These products find applications in various areas such as blood analysis, urine analysis, microbial cell count, cell line viability assessment, and others. End users of automated cell counters include pharmaceutical and biotechnology companies, hospitals, diagnostic laboratories, research institutes, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs have impacted the automated cell counter market by increasing the cost of imported optical components, electronic modules, and precision instruments used in laboratory equipment manufacturing. These higher costs have affected pricing and procurement decisions, particularly for advanced instruments used in pharmaceuticals and research institutes in regions such as north america and asia pacific. Smaller laboratories and academic research centers have been more sensitive to price fluctuations. However, tariffs have also encouraged local manufacturing, regional sourcing of components, and investments in domestic life science instrumentation capabilities, supporting long term supply chain resilience.

The automated cell counter market research report is one of a series of new reports from The Business Research Company that provides automated cell counter market statistics, including automated cell counter industry global market size, regional shares, competitors with an automated cell counter market share, detailed automated cell counter market segments, market trends and opportunities, and any further data you may need to thrive in the automated cell counter industry. This automated cell counter market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The automated cell counter market size has grown strongly in recent years. It will grow from $5.75 billion in 2025 to $6.12 billion in 2026 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to growing reliance on manual cell counting limitations, rising clinical diagnostic testing volumes, increased funding for life science research, expansion of pharmaceutical quality control processes, demand for accurate and repeatable lab results.

The automated cell counter market size is expected to see strong growth in the next few years. It will grow to $7.68 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to growth in personalized medicine research, increasing automation in clinical laboratories, rising adoption of point of care diagnostics, advancements in cell based assays, expansion of biotech research facilities. Major trends in the forecast period include increasing adoption of automated cell counters in clinical diagnostics, rising demand for high throughput cell analysis in research labs, growing preference for optical based automated cell counting systems, expansion of automated cell counters in biopharmaceutical r&d, rising integration of automated cell counting in routine laboratory workflows.

The increasing adoption of personalized medicine is set to drive the growth of the automated cell counter market. Personalized medicine tailors medical treatments to individual patient characteristics, often considering genetic, environmental, and lifestyle factors. This trend is growing due to advancements in genetic research and technology, enabling more precise treatments based on patients' unique profiles. Automated cell counting plays a vital role in personalized medicine by rapidly and accurately analyzing patient-specific cell populations, aiding in the customization of treatments according to individual cellular profiles. For example, the FDA approved 16 new personalized treatments for rare disease patients in February 2024, a significant increase from the 6 approvals in 2022, as reported by the Personalized Medicine Coalition (PMC). This uptrend in personalized medicine adoption will be a key driver for the automated cell counter market's growth.

Leading companies in the automated cell counter market are concentrating on incorporating intelligent algorithms and machine learning, such as the AI automated cell culture system, to streamline and automate cell growth and scalability processes in biological research and biomanufacturing. An AI-automated cell culture system utilizes artificial intelligence to monitor, manage, and optimize cell growth and maintenance autonomously in laboratory settings. For instance, Molecular Devices LLC introduced the CellXpress.ai automated cell culture system in October 2023, featuring machine learning-powered software that simplifies complex cell culture processes. This system integrates an incubator, liquid handler, and imager to automate feeding and passaging schedules, giving scientists more efficiency and control in the lab.

In August 2023, Cell Microsystems, a US-based biotechnology company, acquired Fluxion Biosciences for an undisclosed amount. This acquisition aims to strengthen Cell Microsystems' capabilities in cellular analysis by incorporating Fluxion Biosciences' advanced patch clamp technology and assay tools. Fluxion Biosciences, also based in the US, specializes in developing automated systems and tools for cell-based assays and electrophysiology.

Major companies operating in the automated cell counter market are Thermo Fisher Scientific Inc., Abbott Laboratories, F.Hoffmann-La Roche Ltd., Danaher Corporation, Merck KGaA, BD Biosciences, GE HealthCare Technologies Inc., Corning Incorporated, Agilent Technologies Inc., Olympus Corporation, Nikon Corporation, PerkinElmer Inc., Sysmex Corporation, Bio-Rad laboratories Inc., HORIBA Ltd, Eppendorf, Tecan Group, Miltenyi Biotec, Luminex Corporation, Molecular Devices LLC, Chemometec A/S, NanoEnTek Inc, Sony Biotechnology Inc., Countstar Inc., Aligned Genetics Inc.

North America was the largest region in the automated cell counter market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated cell counter market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the automated cell counter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The automated cell counter market consists of revenues earned by entities by providing services such as instrument installation, maintenance, technical support, training programs, cell counting processes and customization options. The market value includes the value of related goods sold by the service provider or included within the service offering. The automated cell counter market also includes sales of flow cytometers, image-based cell counters, electrical impedance Coulter counters, reagents, calibration standards, and disposable slides or microplates. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Automated Cell Counter Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses automated cell counter market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for automated cell counter ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The automated cell counter market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Automated Cell Counter Market Characteristics

3. Automated Cell Counter Market Supply Chain Analysis

4. Global Automated Cell Counter Market Trends And Strategies

5. Automated Cell Counter Market Analysis Of End Use Industries

6. Automated Cell Counter Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Automated Cell Counter Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Automated Cell Counter Total Addressable Market (TAM) Analysis for the Market

9. Automated Cell Counter Market Segmentation

10. Automated Cell Counter Market Regional And Country Analysis

11. Asia-Pacific Automated Cell Counter Market

12. China Automated Cell Counter Market

13. India Automated Cell Counter Market

14. Japan Automated Cell Counter Market

15. Australia Automated Cell Counter Market

16. Indonesia Automated Cell Counter Market

17. South Korea Automated Cell Counter Market

18. Taiwan Automated Cell Counter Market

19. South East Asia Automated Cell Counter Market

20. Western Europe Automated Cell Counter Market

21. UK Automated Cell Counter Market

22. Germany Automated Cell Counter Market

23. France Automated Cell Counter Market

24. Italy Automated Cell Counter Market

25. Spain Automated Cell Counter Market

26. Eastern Europe Automated Cell Counter Market

27. Russia Automated Cell Counter Market

28. North America Automated Cell Counter Market

29. USA Automated Cell Counter Market

30. Canada Automated Cell Counter Market

31. South America Automated Cell Counter Market

32. Brazil Automated Cell Counter Market

33. Middle East Automated Cell Counter Market

34. Africa Automated Cell Counter Market

35. Automated Cell Counter Market Regulatory and Investment Landscape

36. Automated Cell Counter Market Competitive Landscape And Company Profiles

37. Automated Cell Counter Market Other Major And Innovative Companies

38. Global Automated Cell Counter Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Automated Cell Counter Market

40. Automated Cell Counter Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기